View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
Veeva Systems|21 April 2021

Webinar: Is It Time to Bring Your TMF In-House?

To facilitate virtual TMF inspections and improve efficiency, the EMA encourages sponsors to provide inspectors direct system access to the eTMF on an ongoing basis. In response, sponsors have increased their willingness to bring the eTMF in-house and have CROs work directly within the sponsor eTMF. Although sponsors agree that a sponsor-owned eTMF provides more control, they ask how to implement this strategy successfully. In this webinar, Pinar Benet, senior director of Vault Clinical Operations at Veeva Systems, spoke with Pawel Rucki, senior manager of TMF operations at GW Pharmaceuticals, about GW Pharma’s transition to an in-house TMF model, the benefits of sponsor TMF management, and best practices for making the switch. Originally held on 26 January 2021

While maintaining an active TMF process within your organization can help establish a culture of inspection-readiness, inspection preparation is a distinct process that readies your...
Preparing for a regulatory inspection can be daunting – but it doesn’t have to be. The best approach to reduce the stress of an inspection...
To facilitate virtual TMF inspections and improve efficiency, the European Medicines Agency (EMA) encourages sponsors to provide inspectors direct system access to the eTMF on...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU